About Us > News & Media > News Releases > 2013

The Lancet Neurology: Scientists Identify Early Predictors of Huntington’s Disease Progression Wake Forest Neurologist Applauds Research

Scientists have identified a set of tests that could help identify whether and how Huntington’s disease (HD) is progressing in groups of people who are not yet showing symptoms. The latest findings from the TRACK-HD study, published Online First in The Lancet Neurology, could be used to assess whether potential new treatments are slowing the disease up to 10 years before the development of noticeable symptoms.

Writing in a linked Comment, Francis O. Walker, M.D., Neurology from Wake Forest Baptist Medical Center says that the TRACK-HD investigators have set the standard for observational studies in other neurodegenerative diseases, adding that, “Virtual roadmaps of disease in the minds of practitioners are good for care in the framework of the traditional patient encounter, but it takes substantial effort, teamwork, and genius to turn them into rigorous, quantifiable timelines that can be used to test efficacy in future therapeutic trials.”

For a free abstract of the paper: http://www.thelancet.com/journals/lanneurol/article/PIIS1474-4422(13)70088-7/abstract
Media Relations Contacts:

Quick Reference

News Media Resources

Media Inquiries
336-716-4587
Patient Information
336-713-0000
Satellite Interviews
336-716-4434

Ways to Give

Spotlight

About Us

Learn more about the neurology and neurosurgery program at Wake Forest Baptist Health, offering the best diagnostics, technology and treatment in Winston-Salem, NC.

Last Updated: 05-08-2013
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.